Discusses how drug companies are using modern radiopharmaceutical imaging techniques to support drug discovery.Emphasizes the multidisciplinary nature of Radiopharmaceutical Sciences.Covers key areas of application for diagnosis and therapy in oncology, neurology, and cardiology.Features extensive new and revised content throughout.New chapters cover topics including current Good Manufacturing Practice (cGMP), regulatory oversight, novel approaches to quality control-ensuring that readers are informed of the exciting developments of recent years. This fully revised edition reflects the current state of the field and features substantially updated and expanded content. New radiopharmaceuticals for diagnosis and therapy have been approved by the FDA, the number of clinical PET and SPECT scans have increased significantly, and advances in Artificial Intelligence have dramatically improved research techniques.

Since the first edition of the Handbook was published, Nuclear Medicine and Radiopharmaceutical Sciences have undergone major changes. Contributions from a team of experts from across sub-disciplines provide readers with an immersive examination of radiochemistry, nuclear medicine, molecular imaging, and more. A valuable reference work for those new to the Radiopharmaceutical Sciences and experienced professionals alike, this volume explores the latest concepts and issues involving both targeted diagnostic and therapeutic radiopharmaceuticals.

The second edition of Handbook of Radiopharmaceuticals is a comprehensive review of the field, presenting up-to-date coverage of central topics such as radionuclide production, synthetic methodology, radiopharmaceutical development and regulations, and a wide range of practical applications. The thoroughly updated new edition of the authoritative reference in Radiopharmaceutical Sciences

Endnote free university of michigan